These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of low-dose spironolactone on resistant hypertension. Engbaek M; Hjerrild M; Hallas J; Jacobsen IA J Am Soc Hypertens; 2010; 4(6):290-4. PubMed ID: 21130975 [TBL] [Abstract][Full Text] [Related]
3. Disappearance of spironolactone-induced gynecomastia with triamteren. Yamamoto S Intern Med; 2001 Jun; 40(6):550. PubMed ID: 11446686 [No Abstract] [Full Text] [Related]
7. Ask the doctor. I am a 50-year-old man with congestive heart failure. My doctor has me on all the usual drugs, and a couple of years ago added spironolactone. I did okay with it for a while, but then began to notice that my breasts were getting bigger and began to hurt. My doctor agreed that I should stop taking spironolactone, but I wonder if I am missing out on something. Lee TH Harv Heart Lett; 2003 Oct; 14(2):8. PubMed ID: 14576040 [No Abstract] [Full Text] [Related]
8. [Therapeutic combinations, side effects and interactions of antihypertensive drugs]. Angelino PF Minerva Cardioangiol; 1976 Jun; 24(6):456-64. PubMed ID: 1012494 [No Abstract] [Full Text] [Related]
9. Efficacy of spironolactone therapy in patients with true resistant hypertension. de Souza F; Muxfeldt E; Fiszman R; Salles G Hypertension; 2010 Jan; 55(1):147-52. PubMed ID: 19858405 [TBL] [Abstract][Full Text] [Related]
10. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases. Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459 [No Abstract] [Full Text] [Related]
11. Pathophysiology of spironolactone-induced gynecomastia. Rose LI; Underwood RH; Newmark SR; Kisch ES; Williams GH Ann Intern Med; 1977 Oct; 87(4):398-403. PubMed ID: 907238 [TBL] [Abstract][Full Text] [Related]
12. Electrocardiogram changes in hyperkalemia: there and back again. Zimlichman E; Liran O Isr Med Assoc J; 2005 Nov; 7(11):748. PubMed ID: 16309005 [No Abstract] [Full Text] [Related]
13. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Chapman N; Dobson J; Wilson S; Dahlöf B; Sever PS; Wedel H; Poulter NR; Hypertension; 2007 Apr; 49(4):839-45. PubMed ID: 17309946 [TBL] [Abstract][Full Text] [Related]
14. Antialdosterones: incidence and prevention of sexual side effects. de Gasparo M; Whitebread SE; Preiswerk G; Jeunemaître X; Corvol P; Ménard J J Steroid Biochem; 1989 Jan; 32(1B):223-7. PubMed ID: 2913412 [TBL] [Abstract][Full Text] [Related]
15. Normal ECG or peaked T waves? Hancock EW Hosp Pract (1995); 1998 May; 33(5):19-20. PubMed ID: 9606350 [No Abstract] [Full Text] [Related]
16. [Gynecomastia in spironolactone therapy]. Vetter H Dtsch Med Wochenschr; 1979 May; 104(21):762. PubMed ID: 446292 [No Abstract] [Full Text] [Related]
17. [Therapy of cardiac insufficiency with diuretics]. Holzgreve H Fortschr Med; 1982 Aug; 100(31-32):1449-56. PubMed ID: 7129304 [No Abstract] [Full Text] [Related]
18. Drug treatment of mild hypertension: adverse consequences. Moses C Ann N Y Acad Sci; 1978 Mar; 304():84-98. PubMed ID: 280242 [No Abstract] [Full Text] [Related]
19. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153 [TBL] [Abstract][Full Text] [Related]
20. Sexual dysfunction associated with oral antihypertensive medication: a critical survey of the literature. Moss HB; Procci WR Gen Hosp Psychiatry; 1982 Jul; 4(2):121-9. PubMed ID: 7117827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]